A small 30-patient, one-year confirmatory clinical trial in Japanese patients that compares NeoCart to microfracture

Trial Profile

A small 30-patient, one-year confirmatory clinical trial in Japanese patients that compares NeoCart to microfracture

Planning
Phase of Trial: Phase III

Latest Information Update: 15 Mar 2018

At a glance

  • Drugs Autologous chondrocyte implantation (Primary)
  • Indications Cartilage disorders; Knee injuries
  • Focus Registrational; Therapeutic Use
  • Sponsors Histogenics Corporation
  • Most Recent Events

    • 15 Mar 2018 According to an Histogenics Corporation media release, Histogenics is working closely with MEDINET on the development of NeoCart for the Japanese market and both companies intend to work on the preparation of a clinical trial notification to support this planned trial in Japan in the second half of 2018.
    • 21 Dec 2017 According to a Histogenics Corporation media release, MEDINET and Histogenics went under a collaboration aggrement for develpment and commercialization of NeoCart in Japanese market.
    • 17 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top